GYRE PE ratio history
The average historical PE ratio of Gyre Therapeutics for the last nine years is 58.55. The current PE ratio of 54.43 is 7% below the historical average. In the past nine years, GYRE's PE ratio was at its highest in the Dec 2022 quarter at 197.8, when the stock price was $7.91 and the EPS was $0.04. The lowest value was in the Mar 2023 quarter, when it reached 0.44 with a price of $3.11 and an EPS of $6.98.
Gyre Therapeutics PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 86.43 | N/A | $12.1 | $0.14 |
| 2023 | N/A | N/A | $25.69 | -$1.41 |
| 2022 | 197.8 | N/A | $7.91 | $0.04 |
| 2021 | N/A | N/A | $13.71 | -$43.05 |
| 2020 | N/A | N/A | $94.65 | -$43.95 |
| 2019 | N/A | N/A | $102.15 | -$69 |
| 2018 | N/A | N/A | $118.35 | -$40.2 |
GYRE average PE ratio chart
The current PE ratio of GYRE is lower than the 10-year average.
GYRE PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| GYRE Gyre Therapeutics Inc | 54.43 | $713.33M |
| OLMA Olema Pharmaceuticals Inc | N/A | $217.3M |
| OMER Omeros Corp | N/A | $400.35M |
| ONVO Organovo Holdings Inc | N/A | $2.85M |
| ORIC Oric Pharmaceuticals Inc | N/A | $326.01M |
| ORMP Oramed Pharmaceuticals Inc | N/A | $85.79M |
Frequently asked questions
What is Gyre Therapeutics's PE ratio?
The price to earnings ratio for GYRE stock is 54.43 as of Apr 7, 2025.
What is the highest PE ratio for GYRE?
Over the last nine years, the quarterly PE ratio reached a historic high of 197.8 in the Dec 2022 quarter.
How does the current PE ratio for GYRE compare to its historical average?
The current price to earnings ratio of GYRE is 7% lower than the 9-year historical average.
How is GYRE's PE ratio calculated (Gyre Therapeutics PE ratio formula)?
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Apr 7, 2025), Gyre Therapeutics's stock price is $7.62. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.14. Therefore, Gyre Therapeutics's P/E ratio for today is 54.43. PE RATIO(54.43) = STOCK PRICE($7.62) / TTM EPS($0.14)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.